CEFYBO   02669
CENTRO DE ESTUDIOS FARMACOLOGICOS Y BOTANICOS
Unidad Ejecutora - UE
congresos y reuniones científicas
Título:
Antioxidant treatment normalizes adrenocortical nitric oxide synthase activity and steroid secretion in streptozotocin-diabetic Wistar rats
Autor/es:
SANCHEZ R; REPETTO EM; CIPELLI J; GIORDANINO E; ASTORT F; MARTINEZ CALEJMAN C; MERCAU M; ARIAS P; CYMERYNG C
Lugar:
San Diego, California, EEUU
Reunión:
Congreso; The Endocrine Societys 92nd Annual Meeting; 2010
Institución organizadora:
Endocrine Society
Resumen:
We previously demonstrated that streptozotocin-induced (STZ) diabetes
enhances adrenocortical oxidative / nitrosative stress, modulating
basal and ACTH dependent steroid production. Consequently, present
studies were designed to evaluate the effect of antioxidant treatment
on oxidative stress parameters, nitric oxide synthase (NOS) activity,
and steroidogenic function in the adrenal cortex of STZ-diabetic rats.Control (CON) and STZ-treated male Wistar rats (40 mg/kg ip for two consecutive days) received -tocopherol (-T,
200 mg/kg po), tioctic acid (TA, 90 mg/kg ip), or the corresponding
vehicle every 48 hours, beginning simultaneously with the detection of
hyperglycemia. After 4 weeks, animals were sacrificed and
adrenocortical oxidative stress parameters and NOS activity were
measured. In a second series of experiments, basal and ACTH-stimulated
corticosterone secretion was determined.Antioxidant treatment with -T
or TA had no effect on glycemic levels or on body or relative adrenal
weight. On the other side, these treatments abolished the increase in
TBARS and carbonyl content, and in the expression levels of catalase
and heme oxygenase-1 detected in adrenal cortex homogenates of
STZ-treated rats. Both antioxidants prevented the increase in NOS
activity (CON 88.50.5, STZ 216.79.2, STZ+ -T 108.67.4, STZ+TA 117.416.8 pmol/min/mg protein; p<0.01 vs STZ), and normalized basal (CON 7.32.5, STZ 71.79.2, STZ+ -T 5.83.4, STZ+TA 19.15.5
ng/ml; p<0.001 vs STZ) and ACTH-stimulated corticosterone output in
diabetic rats. Neither antioxidant treatment modified NOS activity or
corticosterone secretion in CON animals.Our results show that, in
STZ-diabetic rats, enhanced oxidative stress is associated with an
increase in the activity of the NO-generating system, a well-known
local modulator of steroid production in the adrenal cortex, and with
altered corticosterone secretion. Systemic antioxidant treatment not
only normalized adrenocortical oxidative stress parameters and NOS
activity in STZ-treated rats, but also corrected the dysregulation in
steroid secretion present in these animals.Sources of Research Support: ANPCyT PICT 2005 N 38283, UBACYT M014 2008-2010; CONICET PIP5